Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Income Statement
Earnings Waterfall
Centessa Pharmaceuticals PLC
Revenue
|
6.9m
USD
|
Operating Expenses
|
-178.1m
USD
|
Operating Income
|
-171.3m
USD
|
Other Expenses
|
20.2m
USD
|
Net Income
|
-151.1m
USD
|
Income Statement
Centessa Pharmaceuticals PLC
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
7
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(10)
|
(26)
|
(62)
|
(319)
|
(154)
|
(188)
|
(218)
|
(229)
|
(212)
|
(208)
|
(187)
|
(178)
|
(178)
|
|
Selling, General & Administrative |
(1)
|
(9)
|
(18)
|
(30)
|
(43)
|
(49)
|
(55)
|
(54)
|
(55)
|
(57)
|
(55)
|
(55)
|
(54)
|
|
Research & Development |
(9)
|
(17)
|
(33)
|
(57)
|
(96)
|
(122)
|
(158)
|
(169)
|
(155)
|
(151)
|
(131)
|
(123)
|
(124)
|
|
Other Operating Expenses |
0
|
0
|
(11)
|
(232)
|
(15)
|
(17)
|
(6)
|
(6)
|
(2)
|
0
|
0
|
0
|
0
|
|
Operating Income |
(10)
N/A
|
(26)
-151%
|
(62)
-137%
|
(319)
-413%
|
(154)
+52%
|
(188)
-22%
|
(218)
-16%
|
(229)
-5%
|
(212)
+7%
|
(208)
+2%
|
(187)
+10%
|
(178)
+5%
|
(171)
+4%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(6)
|
(7)
|
(5)
|
(4)
|
(2)
|
1
|
|
Non-Reccuring Items |
0
|
(220)
|
(220)
|
0
|
(220)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(3)
|
(5)
|
(6)
|
(5)
|
3
|
1
|
2
|
1
|
(6)
|
(5)
|
(5)
|
|
Pre-Tax Income |
(11)
N/A
|
(247)
-2 218%
|
(286)
-16%
|
(324)
-13%
|
(381)
-18%
|
(196)
+49%
|
(220)
-12%
|
(234)
-6%
|
(217)
+7%
|
(213)
+2%
|
(197)
+7%
|
(184)
+6%
|
(176)
+4%
|
|
Net Income | ||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
24
|
27
|
25
|
|
Income from Continuing Operations |
(11)
|
(247)
|
(286)
|
(324)
|
(381)
|
(196)
|
(220)
|
(234)
|
(216)
|
(212)
|
(173)
|
(157)
|
(151)
|
|
Net Income (Common) |
(11)
N/A
|
(247)
-2 218%
|
(286)
-16%
|
(324)
-13%
|
(381)
-18%
|
(196)
+49%
|
(220)
-12%
|
(234)
-6%
|
(216)
+8%
|
(212)
+2%
|
(173)
+19%
|
(157)
+9%
|
(151)
+4%
|
|
EPS (Diluted) |
-0.12
N/A
|
-2.83
-2 258%
|
-3.91
-38%
|
-3.59
+8%
|
-5.07
-41%
|
-2.16
+57%
|
-2.33
-8%
|
-2.47
-6%
|
-2.31
+6%
|
-2.25
+3%
|
-1.82
+19%
|
-1.62
+11%
|
-1.57
+3%
|